Moderna may be holding back its plans for mRNA vaccine production in Africa, but Germany’s BioNTech is filling in the space with an expanded partnership with the Coalition for Epidemic Preparedness Innovations (CEPI). BioNTech announced Wednesday that CEPI had...
CHENGDU, China, May 10, 2024 /PRNewswire/ — WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world’s...
Novavax Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has entered into a co-exclusive licensing agreement with Sanofi. The terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
A personalized mRNA-based cancer vaccine for glioblastoma with an “onion-like” delivery mechanism can prolong survival both in dogs and humans, the results of a small study have suggested. In an article published May 1 in Cell, researchers from the University of...
SAN DIEGO, CA—“The future of cancer vaccines is now.” That’s the first thing that Geneos Therapeutics’ CEO and president, Niranjan Sardesai, PhD, said in an interview with GEN Edge at AACR 2024. “We’re at a point in time where there is no longer any doubt that...
